PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 990.0
(-1.0%)
IDR 990.0
(-1.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 828.79 Billion IDR | -7.26% |
| 2022 | 893.68 Billion IDR | -5.55% |
| 2021 | 946.17 Billion IDR | 25.7% |
| 2020 | 752.74 Billion IDR | 3.36% |
| 2019 | 728.25 Billion IDR | 9.62% |
| 2018 | 664.35 Billion IDR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 864.81 Billion IDR | 4.35% |
| 2024 Q2 | 865.31 Billion IDR | 0.06% |
| 2024 Q3 | 867.87 Billion IDR | 0.3% |
| 2023 Q1 | 915.97 Billion IDR | 2.49% |
| 2023 Q4 | 828.79 Billion IDR | 1.64% |
| 2023 Q3 | 815.38 Billion IDR | -9.82% |
| 2023 FY | 828.79 Billion IDR | -7.26% |
| 2023 Q2 | 904.14 Billion IDR | -1.29% |
| 2022 Q2 | 933.63 Billion IDR | -2.17% |
| 2022 FY | 893.68 Billion IDR | -5.55% |
| 2022 Q4 | 893.68 Billion IDR | 4.47% |
| 2022 Q3 | 855.41 Billion IDR | -8.38% |
| 2022 Q1 | 954.39 Billion IDR | 0.87% |
| 2021 Q3 | 1067.28 Billion IDR | 47.45% |
| 2021 FY | 946.17 Billion IDR | 25.7% |
| 2021 Q1 | - IDR | -100.0% |
| 2021 Q2 | 723.8 Billion IDR | 0.0% |
| 2021 Q4 | 946.17 Billion IDR | -11.35% |
| 2020 FY | 752.74 Billion IDR | 3.36% |
| 2020 Q4 | 752.74 Billion IDR | 0.0% |
| 2019 FY | 728.25 Billion IDR | 9.62% |
| 2018 FY | 664.35 Billion IDR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PT Bundamedik Tbk | 3083.16 Billion IDR | 73.119% |
| PT Metro Healthcare Indonesia Tbk | 4137 Billion IDR | 79.966% |
| PT Medikaloka Hermina Tbk | 8802.65 Billion IDR | 90.585% |
| PT Mitra Keluarga Karyasehat Tbk | 7340.84 Billion IDR | 88.71% |
| PT Murni Sadar Tbk | 1857.07 Billion IDR | 55.371% |
| PT Famon Awal Bros Sedaya Tbk | 4704.03 Billion IDR | 82.381% |
| PT Royal Prima Tbk | 1030.78 Billion IDR | 19.596% |
| PT Sarana Meditama Metropolitan Tbk | 5364.77 Billion IDR | 84.551% |
| PT Siloam International Hospitals Tbk | 10982.06 Billion IDR | 92.453% |
| PT Sejahteraraya Anugrahjaya Tbk | 5606.29 Billion IDR | 85.217% |